To further investigate the effects of celastrol on the metabolism and glycolysis-related signaling pathway in NAFLD mice, firstly, we employed immunofluorescence staining to examine the expression of PKM2 in hepatic macrophages in NAFLD mice. This evidence concerns the gene PKM and metabolic dysfunction-associated steatotic liver disease.